These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 29201613)

  • 1. Genome Editing for Cancer Therapy: Delivery of Cas9 Protein/sgRNA Plasmid via a Gold Nanocluster/Lipid Core-Shell Nanocarrier.
    Wang P; Zhang L; Xie Y; Wang N; Tang R; Zheng W; Jiang X
    Adv Sci (Weinh); 2017 Nov; 4(11):1700175. PubMed ID: 29201613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coassembly of nucleus-targeting gold nanoclusters with CRISPR/Cas9 for simultaneous bioimaging and therapeutic genome editing.
    Tao Y; Yi K; Hu H; Shao D; Li M
    J Mater Chem B; 2021 Jan; 9(1):94-100. PubMed ID: 33220661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination.
    Peng H; Le C; Wu J; Li XF; Zhang H; Le XC
    ACS Nano; 2020 Mar; 14(3):2817-2826. PubMed ID: 32048826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A zwitterionic polymer-inspired material mediated efficient CRISPR-Cas9 gene editing.
    Zhang L; Yang L; Huang J; Chen S; Huang C; Lin Y; Shen A; Zheng Z; Zheng W; Tang S
    Asian J Pharm Sci; 2022 Aug; 17(5):666-678. PubMed ID: 36382298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
    Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
    Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 : single-guide RNA (sgRNA) delivery system in a goat model.
    Huang Y; Ding Y; Liu Y; Zhou S; Ding Q; Yan H; Ma B; Zhao X; Wang X; Chen Y
    Reprod Fertil Dev; 2019 Aug; 31(9):1533-1537. PubMed ID: 31079595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy.
    Wang Y; Tang Y; Zhao XM; Huang G; Gong JH; Yang SD; Li H; Wan WJ; Jia CH; Chen G; Zhang XN
    Acta Biomater; 2022 Nov; 153():481-493. PubMed ID: 36162766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
    Altenbuchner J
    Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy.
    Liu Q; Wang C; Zheng Y; Zhao Y; Wang Y; Hao J; Zhao X; Yi K; Shi L; Kang C; Liu Y
    Biomaterials; 2020 Nov; 258():120275. PubMed ID: 32798741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Nucleic Acid/Gold Nanorod-Based Nanoplatform for Targeted Gene Editing and Combined Tumor Therapy.
    Tang W; Han L; Lu X; Wang Z; Liu F; Li Y; Liu S; Liu S; Tian R; Liu J; Ding B
    ACS Appl Mater Interfaces; 2021 May; 13(18):20974-20981. PubMed ID: 33909408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
    Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
    Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous and endogenous
    Zheng X; Zheng P; Sun J; Kun Z; Ma Y
    Fungal Biol Biotechnol; 2018; 5():2. PubMed ID: 29456867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Delivery of CRISPR/Cas9-Mediated Cancer Gene Therapy via Liposome-Templated Hydrogel Nanoparticles.
    Chen Z; Liu F; Chen Y; Liu J; Wang X; Chen AT; Deng G; Zhang H; Liu J; Hong Z; Zhou J
    Adv Funct Mater; 2017 Dec; 27(46):. PubMed ID: 29755309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.
    Wang HX; Song Z; Lao YH; Xu X; Gong J; Cheng D; Chakraborty S; Park JS; Li M; Huang D; Yin L; Cheng J; Leong KW
    Proc Natl Acad Sci U S A; 2018 May; 115(19):4903-4908. PubMed ID: 29686087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic applications of CRISPR/Cas9 in breast cancer and delivery potential of gold nanomaterials.
    Padayachee J; Singh M
    Nanobiomedicine (Rij); 2020; 7():1849543520983196. PubMed ID: 33488814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
    Hu X; Meng X; Liu Q; Li J; Wang K
    Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms.
    Dong Z; Qin Q; Hu Z; Chen P; Huang L; Zhang X; Tian T; Lu C; Pan M
    Virol Sin; 2019 Aug; 34(4):444-453. PubMed ID: 31218589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.